Literature DB >> 22444791

Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial.

Linda van Wyk1, Kim E Boers, Joris A M van der Post, Maria G van Pampus, Aleid G van Wassenaer, Anneloes L van Baar, Marc E A Spaanderdam, Jeroen H Becker, Anneke Kwee, Johannes J Duvekot, Henk A Bremer, Friso M C Delemarre, Kitty W M Bloemenkamp, Christianne J M de Groot, Christine Willekes, Frans J M E Roumen, Jan M M van Lith, Ben W J Mol, Saskia le Cessie, Sicco A Scherjon.   

Abstract

OBJECTIVE: We sought to study long-term (neuro)developmental and behavioral outcome of pregnancies complicated by intrauterine growth restriction at term in relation to induction of labor or an expectant management. STUDY
DESIGN: Parents of 2-year-old children included in the Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) answered the Ages and Stages Questionnaire (ASQ) and Child Behavior Checklist (CBCL).
RESULTS: We approached 582 (89.5%) of 650 parents. The response rate was 50%. Of these children, 27% had an abnormal score on the ASQ and 13% on the CBCL. Results of the ASQ and the CBCL for the 2 policies were comparable. Low birthweight, positive Morbidity Assessment Index score, and admission to intermediate care increased the risk of an abnormal outcome of the ASQ. This effect was not seen for the CBCL.
CONCLUSION: In women with intrauterine growth restriction at term, neither a policy of induction of labor nor expectant management affect developmental and behavioral outcome when compared to expectant management.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22444791     DOI: 10.1016/j.ajog.2012.02.003

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

1.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 2.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

3.  Parental Alcohol Use, Parenting, and Child On-Time Development.

Authors:  Katarina Guttmannova; Karl G Hill; Jennifer A Bailey; Lacey Hartigan; Candice M Small; J David Hawkins
Journal:  Infant Child Dev       Date:  2016-11-16

4.  The Ages and Stages Questionnaire and Neurodevelopmental Impairment in Two-Year-Old Preterm-Born Children.

Authors:  Jorien M Kerstjens; Ard Nijhuis; Christian V Hulzebos; Deirdre E van Imhoff; Aleid G van Wassenaer-Leemhuis; Ingrid C van Haastert; Enrico Lopriore; Titia Katgert; Renate M Swarte; Richard A van Lingen; Twan L Mulder; Céleste R Laarman; Katerina Steiner; Peter H Dijk
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

5.  Multidisciplinary consensus on screening for, diagnosis and management of fetal growth restriction in the Netherlands.

Authors:  Viki Verfaille; Ank de Jonge; Lidwine Mokkink; Myrte Westerneng; Henriëtte van der Horst; Petra Jellema; Arie Franx
Journal:  BMC Pregnancy Childbirth       Date:  2017-10-16       Impact factor: 3.007

6.  Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy (RATIO37): randomised controlled trial study protocol.

Authors:  Francesc Figueras; Eduard Gratacos; Marta Rial; Ilan Gull; Ladislav Krofta; Marek Lubusky; Rogelio Cruz-Martinez; Mónica Cruz-Lemini; Miguel Martinez-Rodriguez; Pamela Socias; Cristina Aleuanlli; Mauro C Parra Cordero
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

Review 7.  Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.

Authors:  Diana M Bond; Adrienne Gordon; Jon Hyett; Bradley de Vries; Angela E Carberry; Jonathan Morris
Journal:  Cochrane Database Syst Rev       Date:  2015-11-24

8.  Association Between Iatrogenic Delivery for Suspected Fetal Growth Restriction and Childhood School Outcomes.

Authors:  Roshan John Selvaratnam; Euan Morrison Wallace; Rory Wolfe; Peter John Anderson; Mary-Ann Davey
Journal:  JAMA       Date:  2021-07-13       Impact factor: 56.272

9.  Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).

Authors:  Sven Kehl; Jörg Dötsch; Kurt Hecher; Dietmar Schlembach; Dagmar Schmitz; Holger Stepan; Ulrich Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-11-27       Impact factor: 2.915

10.  Assessment of neonatal EEG background and neurodevelopment in full-term small for their gestational age infants.

Authors:  José R Castro Conde; Candelaria González Campo; Nieves L González González; Beatriz Reyes Millán; Desiré González Barrios; Alejandro Jiménez Sosa; Itziar Quintero Fuentes
Journal:  Pediatr Res       Date:  2019-12-10       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.